[Newsroom] Thumbnail GLP1 and AMD Story
June 10, 2025

GLP-1 Agonists Associated with Doubled Risk of Neovascular AMD, Study Finds

Blockbuster meds, blockbuster risks? Trending GLP-1s (like Ozempic) are now raising red flags for nAMD. A new population-based cohort study…

Article 1 Day 1_ ARVO
May 6, 2025

Inspiring Award Lectures at ARVO 2025 Highlight Decades of Visionary Work

Day 2 of the annual meeting of The Association for Research in Vision and Ophthalmology (ARVO 2025) in Salt Lake…

Discover our fascinating content at issuu

explore